Therapeutic Specialist HIV-Franchise (m/f/d) Spezialaussendienst - Region Frankfurt-Giesen-Saarland-Ludwigshafen-Kassel-Freiburg at Gilead Sciences

Frankfurt, Hesse, Germany

Gilead Sciences Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Skills

Key technologies and capabilities for this role

HIV FranchiseInfectiologySales TargetsMedical DoctorsHealthcare ProfessionalsPharmaceutical SalesTherapeutic Specialist

Questions & Answers

Common questions about this position

What is the salary for this Therapeutic Specialist position?

This information is not specified in the job description.

Is this a remote position or does it require travel?

This is a field-based role (Spezialaussendienst) covering a specific geographic region including Frankfurt, Giessen, Saarland, Ludwigshafen, Kassel, and Freiburg, requiring territory management and customer contacts in the assigned area.

What are the key responsibilities for this role?

Responsibilities include achieving sales and coverage targets in the assigned territory, representing Gilead’s products to customers, managing territory budgets, organizing sales initiatives, and operating in compliance with commercial policies.

What is the company culture like at Gilead?

Gilead emphasizes collaboration, determination, and a relentless drive to make a difference, with every employee playing a critical role in scientific innovations; they focus on great leadership, inclusion, development, and empowering employees to fulfill their aspirations.

What makes a strong candidate for this Therapeutic Specialist role?

Strong candidates will have deep knowledge of HIV treatments and infectious diseases, experience discussing scientific product benefits with specialized doctors (Fachärzten in Infectiology), and a proven ability to achieve sales targets in a territory.

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI